ABSTRACT
Myocardial viability imaging with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT), in patients who are appropriate for coronary revascularization, in the presence of left ventricular dysfunction and rest myocardial perfusion defect due to coronary artery disease, has become a frequently used method to differentiate viable myocardial (hibernating) and non-viable myocardial tissues (scar). This guideline, has been prepared by Turkey Society of Nuclear Medicine Cardiology Working Group to provide a standart approach to cardiac viability imaging with F-18 FDG PET/CT. For this purpose details on instrumentation and reporting are summarized and all presented suggestions are submitted by evaluating the international guidelines and current literature.
References
1
Chanda D, Luiken JJ, Glatz JF. Signaling pathways involved in cardiac energy metabolism. FEBS Lett 2016;590:2364-2374.
2
Shao D, Tian R. Glucose transporters in cardiac metabolism and hypertrophy. Compr Physiol 2015;6:331-351.
3
Wolf P, Winhofer Y, Krssak M, et al. Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes. Nutr Metab Cardiovasc Dis 2016;26:387-392.
4
Fillmore N, Mori J, Lopaschuk GD. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br J Pharmacol 2014;171:2080-2090.
5
Azevedo PS, Minicucci MF, Santos PP, et al. Energy metabolism in cardiac remodeling and heart failure. CardiolRev 2013;21:135-140.
6
Elfigih IA, Henein MY. Non-invasive imaging in detecting myocardial viability: Myocardial function versus perfusion. IJC Heart Vasculature 2014;5:51-56.
7
Lehtinen M, Schildt J, Ahonen A, et al. Helsinki BMMC Collaboration. Combining FDG-PET and 99mTc-SPECT to predict function aloutcome after coronary artery bypass surgery. EurHeart J CardiovascImaging 2015;16:1023-1030.
8
Bacharach SL, Bax JJ, Case J, et al. PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol 2003;10:543-556.
9
Wahl RL, Robert SB. Principlesand and Practice of PET and PET/CT. 2nd Edition. Chapter 11.2. Myocardial Viability. Lippincott Williams and Wilkins 2008;565-588.
10
Hansen AK, Gejl M, Bouchelouche K, et al. Reverse Mismatch Pattern in Cardiac 18F-FDG Viability PET/CT Is Not Associated With Poor Outcome of Revascularization: A Retrospective Outcome Study of 91 Patients With Heart Failure. Clin Nucl Med 2016;41:428-435.
11
Ghosh N, Rimoldi OE, Beanlands RS, et al. Assessment of myocardial ischaemia andviability: role of positronemissiontomography. EurHeart J 2010;31:2984-2995.
12
Kobylecka M, Mączewska J, Fronczewska-Wieniawska K, et al. Myocardial viability assessment in 18 FDG PET/CT study. Nucl Med Rev Cent East Eur 2012;15:52-60.
13
Dorbala S, DiCarli MF, Delbeke D, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J NuclMed 2013;54:1485-507.
14
Bhat A, Gan GC, Tan TC, et al. Myocardial viability: From proof of conceptto clinical practice. Cardiol Res Pract 2016;2016:1020818.
15
Ferrari R, Balla C, Malagù M, et al. Reperfusion damage-A story of success, failure and hope. Circ J 2017;81:131-141.
16
Dilsizian V, Bacharach SL, Beanlands RS, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J NuclCardiol 2016;23:1187-1226.
17
Lin E C, Alavi A. Çeviri Editörleri: Basoğlu T, Mavi A. PET ve PET-BT Klinik Kılavuzu. Bölüm 30. Kardiyak PET ve PET-BT. Habitat Yayıncılık 2009;2:263-274.
18
Dilsizian V, Bacharach SL, Beanlands RS, et al. ASNC imaging guidelines for nuclear cardiology procedures: PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 2009. doi:10.1007/s12350-009-9094-9.
19
Vitale GD, deKemp RA, Ruddy TD, et al. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent Diabetes Mellitus, coronary artery disease, and left ventricular dysfunction. J NuclMed 2001;42:1730-1736.
20
Kam BL, Valkema R, Poldermans D, et al. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m) Tc-tetrafosmin after acipimox administration. J NucMed 2003;44:140-145.
21
Yamakawa Y, Takahashi N, Ishikawa T, et al. Clinical usefulness of ECG-gated 18F-FDG PET combined with 99mTC-MIBI gated SPECT for evaluating myocardial viability and function. Ann Nucl Med 2004;18:375-383.
22
Goel PK, Bhatia T, Kapoor A, et al. Left ventricular remodeling after late revascularization correlates with baseline viability. Tex Heart Inst J 2014;41:381-388.
23
Dong W, Li J, Mi H, et al. Relationship between collateral circulation and myocardial viability of 18F-FDG PET/CT subtended by chronic total occluded coronary arteries. Ann Nucl Med 2018;32:197-205.
24
Kıraç FS. Kardiyak PET Perfüzyon ve Viyabilite Çalışmaları. Turkiye Klinikleri J Nucl Med-Special Topics 2015;1:31-40.
25
Zhang F, Yang W, Wang Y, et al. Is there an association between hibernating myocardium and left ventricular mec-hanical dyssynchrony in patients with myocardial infarction? Hell J Nucl Med 2018;21:28-34.